Skip to main content
Equibles

AQR CAPITAL MANAGEMENT LLC

Position in SUPN — Supernus Pharmaceuticals, Inc.

CIK 1167557 Greenwich, CT
Back to SUPN Full portfolio

Position in SUPN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$4,128,040
-$950,861 QoQ
Shares Held
88,756
-9.7% QoQ
Ownership
0.153%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#68
of 335 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority Sole 98% Shared 0% None 2%

Common Shares in SUPN Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

AQR CAPITAL MANAGEMENT LLC holds $1,405,033,456 across 42 Drug Manufacturers - Specialty & Generic names. SUPN ranks #26 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 NBIX
Neurocrine Biosciences Inc
 3,818,037 $643,491,951
2 UTHR
UNITED THERAPEUTICS Corp
 546,002 $295,840,259
3 ZTS
Zoetis Inc.
 1,070,929 $76,956,955
4 VTRS
Viatris Inc
 4,694,966 $74,556,056
5 PRGO
PERRIGO Co plc
 3,480,666 $36,164,117
6 LNTH
Lantheus Holdings, Inc.
 261,250 $28,983,071
7 IRWD
Ironwood Pharmaceuticals Inc
 6,465,921 $27,221,524
8 TAK
Takeda Pharmaceutical Co Ltd
 1,525,686 $24,456,745

All Filings in SUPN

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4,128,040 88,756
2026-03-31 $5,078,901 98,257
2025-12-31 $6,273,628 126,230
2025-09-30 $6,519,843 136,427
2025-06-30 $4,430,355 140,557
2025-03-31 $2,791,084 85,224
2024-12-31 $2,279,597 63,042
2024-09-30 $1,864,905 59,811
2024-06-30 $373,269 13,954
2024-03-31 $468,500 13,735
2023-12-31 $504,279 17,425
2023-09-30 $366,570 13,296
2023-06-30 $320,078 10,648
2023-03-31 $381,791 10,538
2022-12-31 $408,171 11,443
2022-09-30 $278,043 8,214
2022-06-30 $224,014 7,746
2021-09-30 $237,016 8,887
2021-03-31 $234,101 8,942
2020-12-31 $1,215,907 48,327
2020-09-30 $1,410,888 67,701
2020-06-30 $1,988,706 83,735
2020-03-31 $806,131 44,810